48
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting

, , , , , , , & show all
Pages 9-15 | Published online: 18 Dec 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Paula Prieto & Daniel Podzamczer. (2019) Switching strategies in the recent era of antiretroviral therapy. Expert Review of Clinical Pharmacology 12:3, pages 235-247.
Read now
Laura Comi & Franco Maggiolo. (2016) Abacavir + dolutegravir + lamivudine for the treatment of HIV. Expert Opinion on Pharmacotherapy 17:15, pages 2097-2106.
Read now
Franco Maggiolo, Giorgio L Colombo, Sergio Di Matteo, Giacomo M Bruno, Noemi Astuti, Elisa Di Filippo, Giulia Masini & Claudia Bernardini. (2015) Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation. Patient Related Outcome Measures 6, pages 53-60.
Read now

Articles from other publishers (1)

Mazin Barry, Leen Ghonem, Nourah Albeeshi, Maha Alrabiah, Aynaa Alsharidi & Hussain Abdulrahman Al-Omar. (2022) Resource Utilization and Caring Cost of People Living with Human Immunodeficiency Virus (PLHIV) in Saudi Arabia: A Tertiary Care University Hospital Experience. Healthcare 10:1, pages 118.
Crossref